軟骨再生市場：治療モード別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

世界の軟骨再生の市場規模は、2025年～2032年の予測期間中に16.75%のCAGRで拡大し、2024年の15億5,000万米ドルから2032年には53億5,000万米ドルに成長すると予測されています。軟骨再生市場の需要は、関節障害の有病率の増加、その治療のための軟骨再生技術の技術的進歩、軟骨再生市場への投資家の関心の高まりにより、予測数年間で劇的に成長すると予想されます。

軟骨再生は、特に膝、股関節、足首などの関節において、損傷した軟骨を修復または置換する革新的な技術です。軟骨は無血管であり、自己修復に必要な血管やその他の構造を持たないため、変形性関節症やスポーツ障害による損傷は通常、医療介入を必要とします。この市場は、世界の高齢化、スポーツに起因する傷害の発生率の上昇、自然な関節機能を保持する低侵襲治療への受け入れの拡大が、市場を押し上げています。遺伝子治療のさらなる研究や、革新的な新規生体材料の進歩が、この市場のさらなる成長を促進する可能性があります。例えば、2023年11月、医療技術の主要企業であるSmith & Nephew plcは、膝関節治療の先駆的な軟骨再生技術であるAgili-Cを開発したCartiHealを買収することで最終合意したと発表しました。この買収には、最初に1億8,000万米ドルの現金が支払われ、CartiHealの業績に応じてさらに1億5,000万米ドルが支払われます。

当レポートでは、世界の軟骨再生市場について調査し、市場の概要とともに、治療モード別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の軟骨再生市場の見通し、2018年～2032年

• 市場規模の分析と予測
• 市場シェア分析と予測
• 市場マップ分析、2024年
  • 治療モード別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 北米の軟骨再生市場の見通し、2018年～2032年

第6章 欧州の軟骨再生市場の見通し、2018年～2032年

第7章 アジア太平洋の軟骨再生市場の見通し、2018年～2032年

第8章 南米の軟骨再生市場の見通し、2018年～2032年

第9章 中東・アフリカの軟骨再生市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

第18章 特許の情勢

第19章 ケーススタディ

第20章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要参入企業トップ10の情勢
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Orthocell Ltd.
  • Vericel Corporation
  • Geistlich Pharma AG
  • Zimmer Biomet Holdings, Inc.
  • Collagen Solutions plc.
  • CONMED Corporation
  • Medtronic plc
  • Stryker Corporation

第21章 戦略的提言

第22章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 2. Global Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 3. Global Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 4. Global Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 5. Global Cartilage Regeneration Market Share (%), By Region, 2018-2032F
• Figure 6. North America Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 7. North America Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 8. North America Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 9. North America Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 10. North America Cartilage Regeneration Market Share (%), By Country, 2018-2032F
• Figure 11. United States Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 12. United States Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 13. United States Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 14. United States Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 15. Canada Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 16. Canada Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 17. Canada Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 18. Canada Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 19. Mexico Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 20. Mexico Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 21. Mexico Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 22. Mexico Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 23. Europe Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 24. Europe Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 25. Europe Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 26. Europe Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 27. Europe Cartilage Regeneration Market Share (%), By Country, 2018-2032F
• Figure 28. Germany Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 29. Germany Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 30. Germany Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 31. Germany Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 32. France Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 33. France Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 34. France Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 35. France Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 36. Italy Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 37. Italy Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 38. Italy Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 39. Italy Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 40. United Kingdom Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 41. United Kingdom Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 42. United Kingdom Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 43. United Kingdom Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 44. Russia Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 45. Russia Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 46. Russia Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 47. Russia Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 48. Netherlands Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 49. Netherlands Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 50. Netherlands Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 51. Netherlands Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 52. Spain Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 53. Spain Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 54. Spain Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 55. Spain Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 56. Turkey Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 57. Turkey Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 58. Turkey Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 59. Turkey Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 60. Poland Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 61. Poland Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 62. Poland Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 63. Poland Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 64. South America Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 65. South America Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 66. South America Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 67. South America Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 68. South America Cartilage Regeneration Market Share (%), By Country, 2018-2032F
• Figure 69. Brazil Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 70. Brazil Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 71. Brazil Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 72. Brazil Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 73. Argentina Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 74. Argentina Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 75. Argentina Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 76. Argentina Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 77. Asia-Pacific Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 78. Asia-Pacific Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 79. Asia-Pacific Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 80. Asia-Pacific Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 81. Asia-Pacific Cartilage Regeneration Market Share (%), By Country, 2018-2032F
• Figure 82. India Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 83. India Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 84. India Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 85. India Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 86. China Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 87. China Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 88. China Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 89. China Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 90. Japan Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 91. Japan Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 92. Japan Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 93. Japan Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 94. Australia Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 95. Australia Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 96. Australia Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 97. Australia Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 98. Vietnam Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 99. Vietnam Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 100. Vietnam Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 101. Vietnam Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 102. South Korea Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 103. South Korea Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 104. South Korea Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 105. South Korea Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 106. Indonesia Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 107. Indonesia Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 108. Indonesia Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 109. Indonesia Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 110. Philippines Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 111. Philippines Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 112. Philippines Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 113. Philippines Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 114. Middle East & Africa Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 115. Middle East & Africa Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 116. Middle East & Africa Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 117. Middle East & Africa Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 118. Middle East & Africa Cartilage Regeneration Market Share (%), By Country, 2018-2032F
• Figure 119. Saudi Arabia Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 120. Saudi Arabia Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 121. Saudi Arabia Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 122. Saudi Arabia Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 123. UAE Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 124. UAE Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 125. UAE Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 126. UAE Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 127. South Africa Cartilage Regeneration Market, By Value, In USD Billion, 2018-2032F
• Figure 128. South Africa Cartilage Regeneration Market Share (%), By Treatment Mode, 2018-2032F
• Figure 129. South Africa Cartilage Regeneration Market Share (%), By Application, 2018-2032F
• Figure 130. South Africa Cartilage Regeneration Market Share (%), By End-user, 2018-2032F
• Figure 131. By Treatment Mode Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 132. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Global cartilage regeneration market is projected to witness a CAGR of 16.75% during the forecast period 2025-2032, growing from USD 1.55 billion in 2024 to USD 5.35 billion in 2032. The market demand for cartilage regeneration is anticipated to thrive drastically in the forecast years due to the increasing prevalence of joint disorders, technological advancements in cartilage regeneration techniques for their treatment, and the growing interest of investors in the cartilage regeneration market.

Cartilage regeneration is an innovative technique to restore or replace damaged cartilage, especially in joints such as the knee, hip, and ankle. As cartilage is avascular and lacks blood vessels and other structures necessary for self-repair, damage from osteoarthritis or any sports injury usually requires medical intervention. This market is driven upwards by an aging population globally, the increasing incidence of sports-induced injuries, and a growing acceptance of minimally invasive treatments retaining natural joint function. Further studies in gene therapy and advancements in innovative novel biomaterials might propel further growth in this market. For instance, in November 2023, Smith & Nephew plc, a leading global medical technology company, announced a definitive agreement to acquire CartiHeal, Inc., the developer of Agili-C, a pioneering cartilage regeneration technology for knee treatment. The deal involves an initial cash payment of USD 180 million, with an additional USD 150 million contingent on CartiHeal's financial performance.

Increasing Aging Population and Osteoarthritis Incidences

A key growth driver for the cartilage regeneration market is the aging population. As age-related conditions such as osteoarthritis become more common, the demand for cartilage regeneration increases. Osteoarthritis is a condition where joint cartilage gradually breaks down, causing pain, stiffness, and limited mobility, often requiring treatment due to limited self-repair ability. This drives demand for regenerative solutions as people seek alternatives to traditional joint replacements, especially options that restore function with less invasiveness. Increased awareness and improved access to advanced cartilage repair therapies also support market growth as healthcare systems work to meet the needs of an aging population. For instance, in May 2024, Altach Biomedical Ltd, a health-tech startup, raised USD 1.26 million to develop further its innovative biomimetic scaffold for articular cartilage repair, a key factor in preventing osteoarthritis. Originating from research at Trinity College, Dublin, the technology uses type II collagen to mimic natural cartilage, promoting faster and more effective healing.

Advancements in Cartilage Regeneration Techniques

Advancements in cartilage regeneration techniques, like stem cell treatments, biomaterial scaffolds, and gene therapy, are boosting market growth by offering better results and shorter recovery times than traditional methods. Innovations such as biomimetic scaffolds, which mimic natural cartilage, provide more effective and lasting repair options, while stem cell and gene therapies help regenerate cartilage naturally. These advanced treatments give doctors more options and are being increasingly used in clinics as patients and providers seek effective, less invasive solutions. As a result, these advancements are key drivers for growth in the cartilage regeneration market. For instance, in May 2023, Anika Therapeutics, Inc. enrolled the first patient in its pivotal HYALOFAST FastTRACK Phase III clinical trial. The study aims to demonstrate the superiority of HYALOFAST, a hyaluronan-based scaffold combined with autologous bone marrow aspirate concentrate (BMAC), in treating knee cartilage defects. Enrolling approximately 200 patients across 30 sites in the United States and Europe, the trial will evaluate the scaffold's effectiveness in regenerating hyaline-like cartilage.

Cell-Based Therapy Segment to Dominate the Cartilage Regeneration Market

The cell-based therapy segment is anticipated to lead the market, being advanced in therapeutic capability coupled with an increasing number of clinical applications of regenerative medicine. Stem cell-based therapies, in particular, gained attention since these therapies were found to promote tissue regeneration and repair for effective cartilage repair solutions. Autologous or allogeneic stem cells are applied to damaged cartilage to replace or rehabilitate it through differentiation into chondrocytes, which build the cartilage. Recent investments in the cell-based therapy segment have resulted from research and development in stem cell biology, tissue engineering, and cellular delivery techniques. Furthermore, advancements in gene editing technologies continuously enhance the efficacy of cell-based therapies as an even more targeted and efficient promoter for cartilage regeneration.

For instance, in October 2024, Researchers from MIT Alliance for Research and Technology (SMART), Singapore, and the National University of Singapore (NUS) developed a method to enhance mesenchymal stromal cells (MSCs) for cartilage tissue generation by adding ascorbic acid during expansion. They also introduced micro magnetic resonance relaxometry (µMRR), a rapid, label-free tool to monitor MSC quality. This approach addresses challenges in MSC-based therapies for articular cartilage degeneration.

North America Dominates the Cartilage Regeneration Market

Due to advanced healthcare infrastructure, North America is expected to lead the global cartilage regeneration market. According to the Centers for Disease Control and Prevention (CDC), arthritis is a major health crisis; around 1 in 5 United States adults, or 53.2 million people, are affected by it. Among the more than 100 types of arthritis, osteoarthritis (OA) is the most common, impacting 32.5 million adults. This widespread condition highlights the significant demand for effective treatment options, particularly osteoarthritis. Therefore, there is a strong demand for the treatments offered under cartilage regeneration because the aging population commonly suffers from cartilage degeneration as a symptom of old age. The demand for advanced therapies, including cell-based treatments and tissue engineering solutions, is also bolstering the growth of this regional market. The growing interest in less invasive treatments, along with greater patient awareness and acceptance of innovative therapies, position the global cartilage regeneration market. For instance, in March 2024, a UC Davis Health orthopedic surgeon performed the first CartiHeal Agili-C Cartilage Repair Implant in the United States, a new treatment for knee cartilage damage. The implant, absorbed by the body, offers a promising solution for patients with knee pain, helping to preserve cartilage and improve recovery after injury.

Future Market Scenario (2025-2032F)

The future market scenario for the global cartilage regeneration market is likely to be immensely positive, with growth mainly boosted by advancements in regenerative medicine, increased research and development activities, and a rising global prevalence of disorders such as osteoarthritis related to cartilage. These factors, along with a rapidly growing aged population, increasing awareness of modern treatment options, and a movement toward less invasive procedures, will drive this demand through innovative therapies like stem cell treatments, tissue engineering solutions, and biologics. Other important factors, including improved clinical results, shorter recovery times, and more personalized treatment methods, would drive the market further. For instance, in November 2023, cultivate (MD) Capital Funds LP, an investment firm focused on early-stage medical device investments, invested in Nanochon, Inc., specializing in regenerative cartilage technology. Nanochon's Chondrograft implant aids cartilage restoration through a cost-effective, 3D-printed design, providing innovative solutions for sports medicine.

Key Players Landscape and Outlook

The cartilage regeneration market is characterized by its dynamic landscape, shaped by the actions of numerous key players, including significant business agreements and regulatory approvals for various products. The sector has experienced a surge in strategic initiatives, encompassing mergers, acquisitions, and collaborations, reflecting a robust drive for innovation and growth within the industry.

For instance, in April 2024, Hyalex Orthopaedics, Inc., a private medical device company, initiated first-in-human clinical trials for its HYALEX Knee Cartilage System, which uses a unique material engineered to mimic natural cartilage for improved knee function. The trials underway in the United States and Europe assess the safety and performance of the HYALEX implant in patients with knee cartilage loss. This innovative implant aims to provide a novel alternative for knee cartilage repair.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cartilage Regeneration Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Treatment Mode
    • 4.2.1.1. Cell-Based
      • 4.2.1.1.1. Chondrocyte Transplantation
      • 4.2.1.1.2. Growth Factor Technology
    • 4.2.1.2. Non-Cell-Based
      • 4.2.1.2.1. Cell-Free Composites
      • 4.2.1.2.2. Tissue Scaffolds
  • 4.2.2. By Application
    • 4.2.2.1. Fibrocartilage
    • 4.2.2.2. Hyaline Cartilage
  • 4.2.3. By End-user
    • 4.2.3.1. Ambulatory Surgical Centers
    • 4.2.3.2. Hospitals and Clinics
    • 4.2.3.3. Surgical Centers
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Treatment Mode
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. North America Cartilage Regeneration Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Treatment Mode
    • 5.2.1.1. Cell-Based
      • 5.2.1.1.1. Chondrocyte Transplantation
      • 5.2.1.1.2. Growth Factor Technology
    • 5.2.1.2. Non-Cell-Based
      • 5.2.1.2.1. Cell-Free Composites
      • 5.2.1.2.2. Tissue Scaffolds
  • 5.2.2. By Application
    • 5.2.2.1. Fibrocartilage
    • 5.2.2.2. Hyaline Cartilage
  • 5.2.3. By End-user
    • 5.2.3.1. Ambulatory Surgical Centers
    • 5.2.3.2. Hospitals and Clinics
    • 5.2.3.3. Surgical Centers
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Cartilage Regeneration Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Treatment Mode
        • 5.3.1.2.1.1. Cell-Based
        • 5.3.1.2.1.1.1. Chondrocyte Transplantation
        • 5.3.1.2.1.1.2. Growth Factor Technology
        • 5.3.1.2.1.2. Non-Cell-Based
        • 5.3.1.2.1.2.1. Cell-Free Composites
        • 5.3.1.2.1.2.2. Tissue Scaffolds
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Fibrocartilage
        • 5.3.1.2.2.2. Hyaline Cartilage
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Ambulatory Surgical Centers
        • 5.3.1.2.3.2. Hospitals and Clinics
        • 5.3.1.2.3.3. Surgical Centers
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cartilage Regeneration Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Cartilage Regeneration Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Cartilage Regeneration Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Cartilage Regeneration Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Regulatory Approvals
• 17.2. Clinical Trials

18. Patent Landscape

19. Case Studies

20. Competitive Landscape

• 20.1. Competition Matrix of Top 5 Market Leaders
• 20.2. SWOT Analysis for Top 5 Players
• 20.3. Key Players Landscape for Top 10 Market Players
  • 20.3.1. Anika Therapeutics, Inc.
    • 20.3.1.1. Company Details
    • 20.3.1.2. Key Management Personnel
    • 20.3.1.3. Products and Services
    • 20.3.1.4. Financials (As Reported)
    • 20.3.1.5. Key Market Focus and Geographical Presence
    • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 20.3.2. Arthrex, Inc.
  • 20.3.3. Orthocell Ltd.
  • 20.3.4. Vericel Corporation
  • 20.3.5. Geistlich Pharma AG
  • 20.3.6. Zimmer Biomet Holdings, Inc.
  • 20.3.7. Collagen Solutions plc.
  • 20.3.8. CONMED Corporation
  • 20.3.9. Medtronic plc
  • 20.3.10. Stryker Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer